Literature DB >> 1968886

Presentation of antigen to suppressor cells by a dimethylbenz (a) anthracene-resistant, Ia-positive, Thy-1-negative, I-J-restricted epidermal cell.

G M Halliday1, R C Wood, H K Muller.   

Abstract

The epidermal layer of the skin contains class II major histocompatibility (MHC)-positive antigen-presenting cells (APC), the most well characterized population being Langerhans' cells (LC). The chemical carcinogen 7,12 dimethylbenz (a) anthracene (DMBA) depletes about two-thirds of these cells from murine epidermis, and contact sensitizers applied to DMBA-treated skin induce specific immunological tolerance. This tolerance results from epidermal cells migrating to local lymph nodes within 3-6 hr after contact with antigen where they present the antigen to suppressor cells. Here we demonstrate that this epidermal cell which activates suppressor cells is a class II MHC-positive. Thy-1-negative, I-J-restricted APC. Hence at least two types of class II MHC-positive epidermal cells migrate to local lymph nodes and present antigen to lymphocytes; LC, which are sensitive to the effects of DMBA and activate helper lymphocytes, and another, which is resistant to DMBA and activates suppressor cells in an I-J-restricted manner. During the early stages of carcinogenesis any antigen present in the epidermis would be presented only by the cells which activate suppressor lymphocytes, resulting in tolerance induction. This may enable neoplastic cells to avoid the initiation of anti-tumour immunity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968886      PMCID: PMC1385726     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

Review 1.  I-J as a restriction element in the suppressor T cell system.

Authors:  M E Dorf; B Benacerraf
Journal:  Immunol Rev       Date:  1985-04       Impact factor: 12.988

2.  Epidermal I-J-bearing cells are responsible for transferable suppressor cell generation after immunization of mice with ultraviolet radiation-treated epidermal cells.

Authors:  R D Granstein
Journal:  J Invest Dermatol       Date:  1985-03       Impact factor: 8.551

3.  Antigen presentation: comments on its regulation and mechanism.

Authors:  E R Unanue; D I Beller; C Y Lu; P M Allen
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

4.  Epidermal antigen-presenting cells in activation of suppression: identification of a new functional type of ultraviolet radiation-resistant epidermal cell.

Authors:  R D Granstein; A Lowy; M I Greene
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

5.  Relationship between epidermal Langerhans cell density ATPase activity and the induction of contact hypersensitivity.

Authors:  D H Lynch; M F Gurish; R A Daynes
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

6.  Immune suppression by ultraviolet radiation and its role in ultraviolet radiation induced carcinogenesis in mice.

Authors:  F P Noonan; E C De Fabo
Journal:  Australas J Dermatol       Date:  1985-04       Impact factor: 2.875

7.  Structural differences in cell surface T25 polypeptides from thymocytes and cloned T cells.

Authors:  M Sarmiento; M R Loken; F W Fitch
Journal:  Hybridoma       Date:  1981

8.  Differential effects of benzo[a]pyrene and dimethylbenz[a]-anthracene on Langerhans cell distribution and contact sensitization in murine epidermis.

Authors:  J C Ruby; G M Halliday; H K Muller
Journal:  J Invest Dermatol       Date:  1989-02       Impact factor: 8.551

9.  Contact hypersensitivity and Langerhans cells.

Authors:  I Silberberg-Sinakin; G J Thorbecke
Journal:  J Invest Dermatol       Date:  1980-07       Impact factor: 8.551

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  6 in total

1.  Topical and oral retinoids protect Langerhans' cells and epidermal Thy-1+ dendritic cells from being depleted by ultraviolet radiation.

Authors:  K K Ho; G M Halliday; R S Barnetson
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

2.  A role for prostaglandins in the suppression of cutaneous cellular immunity and tumour development in benzo(a)pyrene- but not dimethylbenz(a)anthracene-treated mice.

Authors:  J Andrews; G M Halliday; H K Muller
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Control of Langerhans' cell density by a skin tumour-derived cytokine.

Authors:  G M Halliday; A D Lucas; R S Barnetson
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

4.  Alterations in dendritic cell phenotype and function associated with immunoenhancing effects of a subcutaneously administered cyclophosphamide derivative.

Authors:  J Limpens; M Van Meijer; H M Van Santen; W T Germeraad; K Hoeben-Schornagel; M Breel; R J Scheper; G Kraal
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

Review 5.  Hazardous air pollutants and asthma.

Authors:  George D Leikauf
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

Review 6.  Evaluation of a possible association of urban air toxics and asthma.

Authors:  G D Leikauf; S Kline; R E Albert; C S Baxter; D I Bernstein; J Bernstein; C R Buncher
Journal:  Environ Health Perspect       Date:  1995-09       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.